This report presents key findings that can serve as a platform for middle market life sciences executives looking for insight into their own challenges as well as the challenges faced by their partners in the industry.
We've been recognized from the Biotechnology Innovation Organization (BIO) as their BIO Business Solutions endorsed property casualty insurerand from the Medical Device Manufacturers Association (MDMA).